Page last updated: 2024-09-02

rx 821002 and Allodynia

rx 821002 has been researched along with Allodynia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Castro Perez, A; de Francischi, JN; Gama Duarte, ID; Romero, TR1
Houghton, AK; Westlund, KN1

Other Studies

2 other study(ies) available for rx 821002 and Allodynia

ArticleYear
Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine.
    European journal of pharmacology, 2009, Apr-17, Volume: 608, Issue:1-3

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Dinoprostone; Dose-Response Relationship, Drug; Hyperalgesia; Idazoxan; Imidazoles; Leucine; Male; Naloxone; Opioid Peptides; Pain; Pain Measurement; Rats; Rats, Wistar; Xylazine; Yohimbine

2009
An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis.
    Neuroreport, 1996, Jun-17, Volume: 7, Issue:9

    Topics: Acute Disease; Adrenergic alpha-Antagonists; Animals; Arthritis; Drug Evaluation, Preclinical; Drug Synergism; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Indoles; Injections, Spinal; Isoindoles; Neural Inhibition; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Drug

1996